Owkin believes that medical research should be collaborative, inclusive, and privacy-preserving. Today, Owkin is pioneering AI in healthcare. It leverages its collaborative federated learning software and expert AI capabilities to bring solutions to optimize drug development and improve patient care in oncology. Owkin’s work has been published in Nature Medicine and other top-tier journals. Owkin has raised over $70M from leading VC funds and is now working with the most prominent cancer centers and pharmaceutical companies in Europe and the US. Additionally, Owkin leads several federated learning consortia, including; MELLODDY, to facilitate 'co-opetive' drug discovery between pharma companies, and Healthchain, to allow collaborative research across multiple hospitals. Owkin was co-founded in 2016 by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical hematology, and by Gilles Wainrib, Ph.D., an academic pioneer in the field of Artificial Intelligence in biology.

Biotechnology

Owkin

The Paris office focuses on advanced diagnostics, data science, and AI technology development in healthcare.

Paris

Owkin's headquarters in New York, NY, United States

The London office focuses on innovative biological research, regulatory compliance, and strategic partnerships in the UK.

London

This department analyzes data to derive insights and support decision-making across the organization.

Data Science

This department focuses on scientific research and development to advance knowledge and innovation.

Research Department

The Leadership Team at Owkin drives the strategic vision and operational execution of the company's initiatives in AI-driven healthcare. Comprising top executives from various disciplines, this team collaborates to enhance drug development, foster partnerships with pharmaceutical companies and cancer centers, and lead innovations in federated learning. With a focus on inclusive and privacy-preserving medical research, they ensure that Owkin remains at the forefront of advancing patient care and optimizing collaborative medical research.

Leadership Team

This department focuses on establishing and nurturing partnerships to drive business growth and collaboration.

Partnership Management

The Chief Officers team at Owkin consists of key executives responsible for various strategic domains within the company. They oversee business growth, R&D, solutions development, medical advancements, commercial activities, information security, marketing, diagnostics, growth projects, and people management. This team ensures that Owkin remains at the forefront of AI-driven healthcare innovations, collaborates effectively with cancer centers and pharmaceutical companies, and maintains high standards of security and ethics in their operations.

Chief Officers

The Heads and SVPs team at Owkin comprises senior leaders responsible for steering strategic initiatives, fostering corporate development, and driving impactful collaborations in the healthcare and pharmaceutical sectors. This team oversees critical domains such as drug discovery, oncology, biomedical research, public affairs, data science, diagnostics, partnerships, and internal operations to ensure the company’s mission of pioneering AI in healthcare is successfully executed. Through their leadership, they enable innovative and collaborative approaches to optimize drug development and improve patient outcomes in oncology.

People (19)

Jobs (0)

Other teams

Research Department

Leadership Team

Partnership Management

Chief Officers

Heads and SVPs